These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22083061)

  • 1. Midtrimester dilation and evacuation versus prostaglandin induction: a comparison of composite outcomes.
    Whitley KA; Trinchere K; Prutsman W; Quiñones JN; Rochon ML
    Am J Obstet Gynecol; 2011 Oct; 205(4):386.e1-7. PubMed ID: 22083061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Morbidity of dilatation and evacuation in the second trimester: an analysis].
    Pauli E; Haller U; Zimmermann R
    Gynakol Geburtshilfliche Rundsch; 2005 Apr; 45(2):107-15. PubMed ID: 15818053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D & E midtrimester abortion: a medical innovation.
    Lewit S
    Women Health; 1982; 7(1):49-55. PubMed ID: 7180000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early midtrimester pregnancy termination. A comparison of dilatation and evacuation and intravaginal prostaglandin E2.
    Robins J; Surrago EJ
    J Reprod Med; 1982 Jul; 27(7):415-9. PubMed ID: 6956734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of dilation and evacuation versus the induction of labor for second-trimester pregnancy termination.
    Cowett AA; Golub RM; Grobman WA
    Am J Obstet Gynecol; 2006 Mar; 194(3):768-73. PubMed ID: 16522411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midtrimester pregnancy termination: a study of the cost effectiveness of dilation and evacuation in a free-standing facility.
    Crist T; Williams P; Lee SH; Hulka JF
    N C Med J; 1983 Sep; 44(9):549-51. PubMed ID: 6415492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dilation and evacuation at >or=20 weeks: comparison of operative techniques.
    Chasen ST; Kalish RB; Gupta M; Kaufman JE; Rashbaum WK; Chervenak FA
    Am J Obstet Gynecol; 2004 May; 190(5):1180-3. PubMed ID: 15167815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midtrimester pregnancy termination for fetal malformations. Use of intravaginal prostaglandin E2.
    Hagar DL; Valley MT; Rayburn WF; Carey JC
    J Reprod Med; 1997 Aug; 42(8):497-500. PubMed ID: 9284011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intra-amniotic (15S)-15-methyl-PGF2 alpha and intravaginal prostaglandin E2 for second-trimester uterine evacuation.
    Perry KG; Roberts WE; Martin RW; Magann EF; Sullivan DL; Morrison JC
    J Perinatol; 1998; 18(1):24-7. PubMed ID: 9527940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second trimester termination of pregnancy: a review by site and procedure type.
    Turok DK; Gurtcheff SE; Esplin MS; Shah M; Simonsen SE; Trauscht-Van Horn J; Silver RM
    Contraception; 2008 Mar; 77(3):155-61. PubMed ID: 18279684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal vs. sublingual misoprostol with mifepristone for cervical priming in second-trimester abortion by dilation and evacuation: a randomized clinical trial.
    Carbonell JL; Gallego FG; Llorente MP; Bermudez SB; Sala ES; González LV; Texido CS
    Contraception; 2007 Mar; 75(3):230-7. PubMed ID: 17303495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morbidity and mortality from second-trimester abortions.
    Grimes DA; Schulz KF
    J Reprod Med; 1985 Jul; 30(7):505-14. PubMed ID: 3897528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of complications associated with induction by misoprostol versus dilation and evacuation for second-trimester abortion.
    Sonalkar S; Ogden SN; Tran LK; Chen AY
    Int J Gynaecol Obstet; 2017 Sep; 138(3):272-275. PubMed ID: 28585710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second trimester abortion by extra-amniotic PGF2 alpha infusion: experience of 178 cases.
    Peat B
    Aust N Z J Obstet Gynaecol; 1991 Feb; 31(1):47-51. PubMed ID: 1872774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of two types of prostaglandins for abortion during the second trimester.
    Rettenmaier MA; Hanson FW
    Surg Gynecol Obstet; 1983 May; 156(5):585-8. PubMed ID: 6573807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced second trimester abortion by extra-amniotic prostaglandin infusion in patients with a cesarean scar: is it safe?
    Shapira S; Goldberger S; Beyth Y; Fejgin MD
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):511-4. PubMed ID: 10376860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications of induced abortion.
    Hepburn S
    Fam Plann Inf Serv; 1981 Apr; 1(6):21-8. PubMed ID: 12263451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midtrimester abortion induction with intraamniotic prostaglandin F2 alpha in women with previous uterine surgery.
    Schiff E; Lipitz S; Ben-Baruch G; Chetrit A; Oelsner G; Menczer J
    J Reprod Med; 1991 Mar; 36(3):198-200. PubMed ID: 2030495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of women who undergo second-trimester abortion in the setting of a fetal anomaly.
    Kerns JL; Swanson M; Pena S; Wu D; Shaffer BL; Tran SH; Steinauer JE
    Contraception; 2012 Jan; 85(1):63-8. PubMed ID: 22067803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic sterilization combined with dilation and evacuation up to 18 weeks' gestation.
    Kaali SG; Szigetvari I; Bartfai G; Feinman M
    J Reprod Med; 1989 Jul; 34(7):463-4. PubMed ID: 2527988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.